Kuojun Zhang

1.1k total citations
36 papers, 834 citations indexed

About

Kuojun Zhang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Kuojun Zhang has authored 36 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 19 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in Kuojun Zhang's work include CAR-T cell therapy research (12 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Immune Cell Function and Interaction (5 papers). Kuojun Zhang is often cited by papers focused on CAR-T cell therapy research (12 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Immune Cell Function and Interaction (5 papers). Kuojun Zhang collaborates with scholars based in China and United States. Kuojun Zhang's co-authors include Sheng Jiang, Xiaoxing Wu, Tianyu Wang, Jinxin Wang, Haiping Hao, Xiangyu Zhang, Zheng Li, Kun Ma, Kan Yang and Minghui Wang and has published in prestigious journals such as Journal of Medicinal Chemistry, RSC Advances and European Journal of Medicinal Chemistry.

In The Last Decade

Kuojun Zhang

34 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kuojun Zhang China 16 391 327 165 124 102 36 834
Heying Pei China 18 427 1.1× 150 0.5× 289 1.8× 94 0.8× 74 0.7× 56 935
Xuanxuan Dai China 23 683 1.7× 263 0.8× 88 0.5× 82 0.7× 77 0.8× 40 1.2k
Simon Wing Fai Mok Macao 21 598 1.5× 205 0.6× 161 1.0× 75 0.6× 29 0.3× 35 1.0k
Long-Shan Li United States 8 498 1.3× 283 0.9× 121 0.7× 51 0.4× 26 0.3× 10 813
Malina Patel United States 4 420 1.1× 259 0.8× 112 0.7× 45 0.4× 25 0.2× 5 679
Jin-Zhang Zeng China 22 708 1.8× 105 0.3× 136 0.8× 205 1.7× 47 0.5× 49 1.1k
Samriddhi Shukla India 19 729 1.9× 208 0.6× 119 0.7× 56 0.5× 33 0.3× 26 1.1k
Ming Ji China 21 692 1.8× 316 1.0× 252 1.5× 260 2.1× 39 0.4× 73 1.4k
Jubo Wang China 18 799 2.0× 280 0.9× 151 0.9× 54 0.4× 51 0.5× 52 1.2k
Małgorzata Drąg‐Zalesińska Poland 17 435 1.1× 101 0.3× 67 0.4× 62 0.5× 77 0.8× 47 876

Countries citing papers authored by Kuojun Zhang

Since Specialization
Citations

This map shows the geographic impact of Kuojun Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuojun Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuojun Zhang more than expected).

Fields of papers citing papers by Kuojun Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuojun Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuojun Zhang. The network helps show where Kuojun Zhang may publish in the future.

Co-authorship network of co-authors of Kuojun Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Kuojun Zhang. A scholar is included among the top collaborators of Kuojun Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuojun Zhang. Kuojun Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Yao, Kaizhen Wang, Xiang Ni, et al.. (2025). Discovery, Synthesis, and Activity Evaluation of Novel Small-Molecule Inhibitors Targeting VISTA for Cancer Immunotherapy. Journal of Medicinal Chemistry. 68(5). 5222–5237. 1 indexed citations
2.
Wang, Kaizhen, Lin Wang, Qi Miao, et al.. (2025). Discovery of a Novel Potent and Orally Efficacious PROTAC Degrader of HPK1 for Tumor Immunotherapy. Journal of Medicinal Chemistry. 68(15). 15991–16017.
3.
Wang, Kaizhen, Wanheng Zhang, Dexiang Wang, et al.. (2025). Discovery of dual PARP/NAMPT inhibitors for the treatment of BRCA wild-type triple-negative breast cancer. Bioorganic & Medicinal Chemistry Letters. 120. 130117–130117. 2 indexed citations
4.
Mao, Jie, Yuxing Wu, Kaizhen Wang, et al.. (2025). Discovery of 1,2,4-benzotriazine derivatives as new hematopoietic progenitor kinase 1 (HPK1) inhibitors. Bioorganic Chemistry. 156. 108158–108158. 2 indexed citations
5.
Wang, Kaizhen, Xiangyu Zhang, Yingxin Hu, et al.. (2024). Discovery of novel phenyl urea SHP2 inhibitors with anti-colon cancer and potential immunomodulatory effects. European Journal of Medicinal Chemistry. 281. 117036–117036. 2 indexed citations
6.
Wang, Kaizhen, Xiang Ni, Sheng Jiang, et al.. (2024). Discovery of small molecules for autophagy-lysosome degradation of immune checkpoint proteins. European Journal of Medicinal Chemistry. 280. 116958–116958. 1 indexed citations
7.
Wang, Kaizhen, Yao Cheng, Xiang Ni, et al.. (2024). Discovery of Benzo[d]oxazoles as Novel Dual Small-Molecule Inhibitors Targeting PD-1/PD-L1 and VISTA Pathway. Journal of Medicinal Chemistry. 67(20). 18526–18548. 3 indexed citations
8.
Wang, Kaizhen, Hongtao Shen, Tianyu Wang, et al.. (2023). Discovery of diaminotriazine carboxamides as potent inhibitors of hematopoetic progenitor kinase 1. Bioorganic Chemistry. 138. 106682–106682. 5 indexed citations
9.
Wang, Kaizhen, Ke Ye, Xinyuan Zhou, et al.. (2023). Design, synthesis, and evaluation of PD-1/PD-L1 small-molecule inhibitors bearing a rigid indane scaffold. European Journal of Medicinal Chemistry. 256. 115468–115468. 15 indexed citations
10.
Tang, He, Lin Wang, Tianyu Wang, et al.. (2023). Recent advances of targeting nicotinamide phosphoribosyltransferase (NAMPT) for cancer drug discovery. European Journal of Medicinal Chemistry. 258. 115607–115607. 19 indexed citations
11.
Wang, Kaizhen, Ke Ye, Xiangyu Zhang, et al.. (2023). Dual Nicotinamide Phosphoribosyltransferase (NAMPT) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors for the Treatment of Drug-Resistant Nonsmall-Cell Lung Cancer. Journal of Medicinal Chemistry. 66(1). 1027–1047. 18 indexed citations
12.
Zhang, Kuojun, Tianyu Wang, Maotian Li, et al.. (2023). Discovery of quinazolin-4-one-based non-covalent inhibitors targeting the severe acute respiratory syndrome coronavirus 2 main protease (SARS-CoV-2 Mpro). European Journal of Medicinal Chemistry. 257. 115487–115487. 14 indexed citations
13.
Ye, Ke, Kaizheng Wang, Tianyu Wang, et al.. (2023). Design, synthesis, biological evaluation of urea substituted 1,2,5-oxadiazole-3-carboximidamides as novel indoleamine 2,3-dioxygenase-1 (IDO1) inhibitors. European Journal of Medicinal Chemistry. 250. 115217–115217. 8 indexed citations
14.
Wang, Tianyu, et al.. (2022). The development of small-molecule inhibitors targeting HPK1. European Journal of Medicinal Chemistry. 244. 114819–114819. 37 indexed citations
15.
Zhang, Kuojun, Kaizhen Wang, Xiangyu Zhang, et al.. (2022). Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer. Journal of Medicinal Chemistry. 65(11). 7746–7769. 22 indexed citations
16.
Zhang, Wanheng, Kuojun Zhang, Yiwu Yao, et al.. (2020). Dual nicotinamide phosphoribosyltransferase and epidermal growth factor receptor inhibitors for the treatment of cancer. European Journal of Medicinal Chemistry. 211. 113022–113022. 15 indexed citations
17.
Zhang, Kuojun, Yong Ni, Jiaxuan Chen, et al.. (2019). Discovery of trans-3-(pyridin-3-yl)acrylamide-derived sulfamides as potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitors for the potential treatment of cancer. Bioorganic & Medicinal Chemistry Letters. 29(12). 1502–1506. 16 indexed citations
18.
Wang, Tianyu, Xiaoxing Wu, Changying Guo, et al.. (2018). Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway. Journal of Medicinal Chemistry. 62(4). 1715–1730. 96 indexed citations
19.
Zhang, Kuojun, et al.. (2018). NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer. Journal of Medicinal Chemistry. 61(16). 6983–7003. 169 indexed citations
20.
Wang, Minghui, et al.. (2017). Pharmacology of mangostins and their derivatives: A comprehensive review. Chinese Journal of Natural Medicines. 15(2). 81–93. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heying Pei Breakdown of academic impact, for papers by Xuanxuan Dai Breakdown of academic impact, for papers by Simon Wing Fai Mok Breakdown of academic impact, for papers by Long-Shan Li Breakdown of academic impact, for papers by Malina Patel Breakdown of academic impact, for papers by Jin-Zhang Zeng Breakdown of academic impact, for papers by Samriddhi Shukla Breakdown of academic impact, for papers by Ming Ji Breakdown of academic impact, for papers by Jubo Wang Breakdown of academic impact, for papers by Małgorzata Drąg‐Zalesińska
Rankless by CCL
2026